eFFECTOR Therapeutics, based in San Diego, CA, is a pioneering biopharmaceutical company dedicated to revolutionizing cancer treatment. Their team of industry veterans is focused on developing selective translational regulator inhibitors (STRIs) to outsmart cancer's complexity and provide more effective options for patients.
By blocking the production of cancer-driving proteins and enabling existing oncology therapies to work better, eFFECTOR Therapeutics aims to bring a fundamentally new approach to activating the immune system and fighting cancer. Their innovative research and dynamic outlook position them at the forefront of advancing oncology treatments.
Generated from the website